AstraZeneca
AstraZeneca is constructing a new biologics manufacturing campus in Singapore, focusing on biologics and small molecule APIs. The company aims to innovate in pharmaceutical manufacturing with a sustainable, digital, and automated approach, contributing to life-changing medicines worldwide.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
Director, Technical Operations (Small Molecule Drug Product)
Merck & Co., Inc.
Director, Technical Operations (Small Molecule Drug Substance)
Merck & Co., Inc.
Associate Director Process Engineering – Small Molecule Active Pharmaceutical Ingredients (API)
Eli Lilly and Company
Process Engineer, Technical Operations – Small Molecule Drug Substance
Merck & Co., Inc.
Senior Scientist, Small Molecule Chemical Engineering
MSD
Process Engineer III/ IV- Small Molecule/ Oligo/ Peptide
CRB